Glycemic management of type 2 diabetes mellitus

New England Journal of Medicine

Volumn 367, Issue 2, 2012, Pages 183-

  Grajower, Martin M ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; GLIBENCLAMIDE; GLIMEPIRIDE; GLIPIZIDE; SULFONYLUREA DERIVATIVE;

CARDIOVASCULAR RISK; GLYCEMIC CONTROL; HUMAN; HYPOGLYCEMIA; ISCHEMIC PRECONDITIONING; LETTER; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; SIDE EFFECT; WEIGHT GAIN;

EID: 84863664173     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1205238     Document Type: Letter

References (2)

1. Riddle MC. Sulfonylureas differ in effects on ischemic preconditioning - is it time to retire glyburide? J Clin Endocrinol Metab 2003;88:528-30. (Pubitemid 36207784)
2. Idem. More reasons to say goodbye to glyburide. J Clin Endocrinal Metab 2010;95:4867-70.